CXCL10   Click here for help

GtoPdb Ligand ID: 835

Immunopharmacology Ligand
Comment: CXCL10 is a C-X-C motif chemokine preferentially expressed by Th1 lymphocytes. It exerts its biological effects via interaction with the CXCR3 GPCR.
Species: Human
Click here for help
References
1. Deshpande S, Huang H, Srinivasan M, Cardarelli JM, Wang C, Passmore DB, Rangan V, Lane TE, Keirstead HS, Liu MT. (2012)
IP-10 antibodies and their uses.
Patent number: US8258266 B2. Assignee: Medarex, Inc.. Priority date: 10/12/2003. Publication date: 04/09/2012.
2. Heise CE, Pahuja A, Hudson SC, Mistry MS, Putnam AL, Gross MM, Gottlieb PA, Wade WS, Kiankarimi M, Schwarz D et al.. (2005)
Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
J Pharmacol Exp Ther, 313 (3): 1263-71. [PMID:15761110]
3. Lee EY, Lee ZH, Song YW. (2009)
CXCL10 and autoimmune diseases.
Autoimmun Rev, 8 (5): 379-83. [PMID:19105984]
4. Weng Y, Siciliano SJ, Waldburger KE, Sirotina-Meisher A, Staruch MJ, Daugherty BL, Gould SL, Springer MS, DeMartino JA. (1998)
Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors.
J Biol Chem, 273 (29): 18288-91. [PMID:9660793]
5. Zhang H, Maqsudi S, Rainczuk A, Duffield N, Lawrence J, Keane FM, Justa-Schuch D, Geiss-Friedlander R, Gorrell MD, Stephens AN. (2015)
Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis.
FEBS J, 282 (19): 3737-57. [PMID:26175140]